Live Breaking News & Updates on Delaware group equity fds
Stay updated with breaking news from Delaware group equity fds. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
In the last trading session, 0.42 million Compugen Ltd. (NASDAQ:CGEN) shares changed hands as the company’s beta touched 2.67. With the company’s per share price at $0.74 changed hands at -$0.01 or -1.31% during last session, the market valuation stood at $65.02M. CGEN’s last price was a disco
During the last session, Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD)’s traded shares were 2.18 million, with the beta value of the company hitting 1.16. At the end of the trading day, the stock’s price was $0.30, reflecting an intraday loss of -3.29% or -$0.01. The 52-week high for the GLM
Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) has a beta value of 1.96 and has seen 2.23 million shares traded in the recent trading session. The company, currently valued at $48.41M, closed the recent trade at $1.62 per share which meant it lost -$0.26 on the day or -14.06% during that session. The GLM
Vascular Biogenics Ltd. (NASDAQ:VBLT): Can A Stock That's Up 1.852% YTD Still Be Considered In Loss Territory? marketingsentinel.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketingsentinel.com Daily Mail and Mail on Sunday newspapers.
What Will ProQR Therapeutics N.V. (NASDAQ:PRQR) Be Like After It Drops -45.31% From Its Highs? marketingsentinel.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketingsentinel.com Daily Mail and Mail on Sunday newspapers.
Sio Gene Therapies Inc. Is A Buy Small Cap Stock: Analysts marketingsentinel.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketingsentinel.com Daily Mail and Mail on Sunday newspapers.
During the last session, Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD)’s traded shares were 0.35 million, with the beta value of the company hitting 2.17. At the end of the trading day, the stock’s price was $3.39, reflecting an intraday gain of 4.63% or $0.15. The 52-week high for the GLMD
During the last session, Sio Gene Therapies Inc. (NASDAQ:SIOX)’s traded shares were 0.33 million, with the beta value of the company hitting 1.75. At the end of the trading day, the stock’s price was $2.49, reflecting an intraday gain of 1.63% or $0.04. The 52-week high for the SIOX share is $5.74, that puts it down -130.52 from that peak though still a striking 25.3% gain since the share price plummeted to a 52-week low of $1.86. The company’s market capitalization is $144.27M, and the average intraday trading volume over the past 10 days was 0.34 million shares, and the average trade volume was 625.18K shares over the past three months.
In the last trading session, 245,891 Vascular Biogenics Ltd. (NASDAQ:VBLT) shares changed hands as the company’s beta touched 0.94. With the company’s per share price at $2.36 changed hands at $0.07 or 0.03% during last session, the market valuation stood at $142.27 Million. VBLT’s last price
In last trading session, Sio Gene Therapies Inc. (NASDAQ:SIOX) saw 563,596 shares changing hands with its beta currently measuring 1.72. Company’s recent per share price level of $2.67 trading at $0.19 or 7.66% at ring of the bell on the day assigns it a market valuation of $156.86 Million. That closing price of SIOX’s stock is at a discount of -114.98% from its 52-week high price of $5.74 and is indicating a premium of 30.34% from its 52-week low price of $1.86. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 834.2 Million shares which gives us an average trading volume of 1.58 Million if we extend that period to 3-months.